PFG Investments’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$662K Sell
15,512
-1,882
-11% -$102K 0.03% 547
2026
Q1
$1.09M Buy
17,394
+5,045
+41% +$404K 0.05% 344
2025
Q4
$1.18M Buy
12,349
+676
+6% +$66.3K 0.06% 308
2025
Q3
$1.14M Buy
11,673
+3,270
+39% +$339K 0.06% 297
2025
Q2
$903K Buy
8,403
+503
+6% +$50.9K 0.05% 333
2025
Q1
$797K Sell
7,900
-213
-3% -$21.4K 0.05% 352
2024
Q4
$725K Buy
8,113
+125
+2% +$11K 0.05% 371
2024
Q3
$669K Buy
7,988
+258
+3% +$20.3K 0.04% 396
2024
Q2
$595K Sell
7,730
-155
-2% -$11.3K 0.04% 392
2024
Q1
$540K Buy
7,885
+2,997
+61% +$193K 0.03% 499
2023
Q4
$283K Buy
4,888
+105
+2% +$5.61K 0.05% 365
2023
Q3
$253K Sell
4,783
-3,964
-45% -$208K 0.05% 395
2023
Q2
$473K Buy
+8,747
New +$457K 0.08% 256

Other funds holding BSX

PFG Investments's BSX Position: Q2 2026 in Review

PFG Investments reduced its Boston Scientific (BSX) stake by 11% in Q2 2026, selling an estimated $102K and leaving 15,512 shares worth $662K. The position accounts for 0.03% of the portfolio, ranked #547.

PFG Investments first reported a position in BSX in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.18M in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • PFG Investments held 15,512 shares of Boston Scientific worth $662K as of Q2 2026.
  • PFG Investments sold 1,882 Boston Scientific shares in Q2 2026, an estimated $102K.
  • Boston Scientific made up 0.03% of PFG Investments's portfolio in Q2 2026, its #547 holding.
  • PFG Investments first reported a position in Boston Scientific in Q2 2023 and has held it in 13 quarters since.
  • PFG Investments's Boston Scientific position peaked at $1.18M in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.